Hritis Rheum. 40, 1612?04 (1997). two. Cho, J. H. Feldman, M. Heterogeneity of autoimmune ailments: pathophysiologic insights from genetics and implications for new therapies. Nat. Med. 21, 730?38 (2015). three. Ruffatti, A. et al. Anti-double-stranded DNA antibodies inside the healthy Urea Inhibitors targets elderly: prevalence and qualities. J. Clin. Immunol. ten, 300?03 (1990). four. Rubin, R. L., Teodorescu, M., Beutner, E. H. Plunkett, R. W. Complement-fixing properties of antinuclear antibodies distinguish drug-induced lupus from systemic lupus erythematosus. Lupus 13, 249?56 (2004). 5. DeGiorgio, L. A., Konstantinov, K. N. Diamond, B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat. Med. 7, 1189?193 (2001). six. Sun, K.-H., Yu, C.-L., Tang, S.-J. Sun, G.-H. Monoclonal anti-double-stranded DNA autoantibody stimulates the expression and release of IL-1, IL-6, IL-8, IL-10 and TNF- from standard human mononuclear cells involving within the lupus pathogenesis. Immunology 99, 352?60 (2000). 7. Sprangers, B., Monahan, M. Appel, G. B. Diagnosis and therapy of lupus nephritis flares – an update. Nat. Rev. Nephrology 8, 709?17 (2012). eight. Lau, C. S. Mak, A. The socioeconomic burden of SLE. Nat. Rev. Rheumatol. five, 400?04 (2009). 9. Pisetsky, D. S. Anti-DNA antibodies – quintessential biomarkers of SLE. Nat. Rev. Rheumatol. 12, 102?10 (2016). 10. Liu, C. C., Kao, A. H., Manzi, S. Ahearn, J. M. Biomarkers in systemic lupus erythematosus: challenges and prospects for the future. Ther. Adv. Musculoskelet. Dis. five, 210?33 (2013). 11. Welsh, R. Vyska, K. Phosphopeptides in very purified calf thymusDNA. Standard Appl. Histochem. 31, 281?98 (1987). 12. Porsch, B., Laga, R., Horsk? J., Ko , C. Ulbrich, K. Molecular weight and polydispersity of calf-thymus DNA: static light-scattering and size-exclusion chromatography with dual detection. Biomacromolecules ten, 3148?150 (2009). 13. Sanguineti, S. et al. Particular recognition of a DNA immunogen by its elicited antibody. J. Mol. Biol. 370, 183?95 (2007). 14. Stevens, S. Y., Swanson, P. C., Voss, E. W. Jr. Glick, G. D. Proof for induced fit in antibody-DNA complexes. J. Am. Chem. Soc. 115, 1585?586 (1993). 15. Barbas, S. M., Ghazal, P., Barbas, C. F. III Burton, D. R. Recognition of DNA by synthetic antibodies. J. Am. Chem. Soc. 116, 2161?162 (1994). 16. Tran, T. N. et al. A universal DNA-based protein detection method. J. Am. Chem. Soc. 135, 14008?4011 (2013). 17. An, Y., Raju, R. K., Lu, T. Wheeler, S. E. Aromatic interactions modulate the 5-base selectivity with the DNA-binding autoantibody ED-10. J. Phys. Chem. B 118, 5653?659 (2014). 18. Chiaro, T. R., Davis, K. W., Wilson, A., Suh-Lailam, B. Tebo, A. E. Evaluation of a higher avidity anti-dsDNA IgG enzyme-linked immunosorbent assay for the diagnosis of systemic lupus erythematosus. Clin. Chim. Acta 412, 1076?080 (2011). 19. Pavlovic, M. et al. Pathogenic and Epiphenomenal Anti-DNA Antibodies in SLE. Autoimmune Dis. 2010, Write-up ID462841 (2010). 20. Fernando, H., Rodriguez, R. Balasubramanian, S. Selective recognition of a DNA G-quadruplex by an engineered antibody. Biochemistry 47, 9365?371 (2008). 21. Brunner, H. I., Huggins, J. Klein-Gitelman, M. S. Pediatric SLE – towards a comprehensive management plan. Nat. Rev. Rheumatol. 7, 225?33 (2011). 22. Samuelsen, S. V. et al. Synthetic oligonucleotide Aumitin manufacturer antigens modified with locked nucleic acids detect disease particular antibodies. Sci. Rep. 6, 35827 (2016).
